Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Home
Clinical Trial Updates
Page 3
Clinical Trial Updates
Clinical trial updates
U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia
Editorial Team
-
October 16, 2020
ESMO 2020: Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC
ESMO 2020: Olaparib Improves Median Time Without Disease Progression in BRCAm Ovarian Cancer
ARAMIS Study Show Significantly Longer Overall Survival with Darolutamide in Non-metastatic CRPC
Adjuvant Dabrafenib + Trametinib in Resected Stage III Melanoma w/BRAF Mutations: 5-Year Follow-up
Highly Focused Radiation may Slow Down Progression in Men with Prostate...
Peter Hofland, Ph.D
-
March 26, 2020
Survey Shows COVID19 Expected to Slow Down Global Drug Development
Peter Hofland, Ph.D
-
March 26, 2020
Lung Cancer Studies Sponsored by Pharma are Not More Biased than...
Peter Hofland, Ph.D
-
March 25, 2020
Study Shows Positive Topline Results from Phase III Trial of Venetoclax...
Editorial Team
-
March 23, 2020
Debio 0123, a Potent WEE1 Inhibitor, to be Assessed in First-in-human,...
Peter Hofland, Ph.D
-
March 6, 2020
FDA Advisory Committee Favors Ramucirumab as First-Line Treatment for EGFR-Mutated NSCLC
Peter Hofland, Ph.D
-
March 4, 2020
Priority Review for Kite’s KTE-X19 Biologics License Application in R/R Mantle...
Peter Hofland, Ph.D
-
March 4, 2020
+RNAinsight™ Identifies More Patients with Increased Hereditary Cancer Risk vs. DNA-only...
Peter Hofland, Ph.D
-
February 25, 2020
Drinking Milk May Increase Rate of Breast Cancer by up to...
Editorial Team
-
February 25, 2020
Phase II Trial of Cabiralizumab + Nivolumab Does Not Meet Primary...
Peter Hofland, Ph.D
-
February 20, 2020
1
2
3
4
...
23
Page 3 of 23
LATEST NEWS
AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses
Peter Hofland, Ph.D
-
April 13, 2021
A Spaceship on Mars and Screening for Gynecologic Cancer
Valena Wrtight, MD
-
April 6, 2021
Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?
Michael C. Dugan, M.D.
-
April 1, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
Ofer Sharon, MD, MBA
-
March 22, 2021